Related by context. All words. (Click for frequent words.) 69 microalbumin 65 calculated creatinine clearance 65 mcg albinterferon alfa 2b 65 advanced adenoma 64 placebo dexamethasone 64 digital rectal examination 64 advanced adenomas 64 ALT flares 63 mL/min/#.# m2 63 advanced neoplasia 63 detectable BPA 63 seroconverted 63 specific antigen PSA 63 Index CDAI 63 undergone radical prostatectomy 63 asymptomatic carotid stenosis 63 low dose Iluvien 63 mL/min/#.# m 2 63 elevated ALT 63 undetectable HBV DNA 63 Postoperative complications 63 hemoglobin A1c HbA1c 63 Homocysteine levels 63 relapsed MM 62 ONGLYZA saxagliptin 62 Prostate Specific Antigen PSA 62 hemoglobin A1C 62 preintervention 62 del 5q MDS 62 colorectal neoplasia 62 underwent surgical resection 62 #.#ng/ml 62 poor metabolizers 62 achieved ACR# 62 HCV antibody 62 elevated serum creatinine 61 glycated hemoglobin levels 61 biochemical relapse 61 estimated glomerular filtration 61 Liver biopsies 61 CIN3 61 PSA nadir 61 elevated LDH 61 urine cytology 61 renal cell carcinomas 61 infliximab monotherapy 61 CIN3 + 61 malignant polyps 61 underwent CABG 61 NHANES III 61 amoxicillin clavulanate 61 hydroxyvitamin D levels 61 liver biopsies 61 pCR 61 posttransplant 61 nonpregnant women 61 sleeve lobectomy 61 TEAEs 61 retrospective cohort 61 glomerular filtration 61 SGPT 61 lifetime abstainers 61 urine albumin 60 pelvic ultrasound 60 definite stent thrombosis 60 evaluable subjects 60 perimenopausal women 60 HbA 1c levels 60 mIU ml 60 Fasting blood glucose 60 % CI #.#-#.# [003] 60 abdominal computed tomography 60 serum phosphorous 60 X ULN 60 estimated GFR 60 Crohn Disease Activity 60 baseline HbA1c 60 SUVmax 60 hepatitis C genotype 60 serum PSA 60 systolic dysfunction 60 CIN2 + 60 generalized edema 60 lopinavir r arm 60 #OHD levels 60 HBV infections 60 PASI scores 60 ASCUS 60 MMSE scores 60 Fasting glucose levels 60 PREZISTA r arm 60 ALT elevation 60 mmol l 60 R0 resection 60 seropositivity 60 laparoscopically assisted 60 glycated hemoglobin HbA1c 60 Skin sterol 60 glulisine 59 test FOBT 59 oxycodone CR 59 aspartate aminotransferase AST 59 FDG PET scans 59 chest radiographs 59 DEXA scans 59 highly emetogenic 59 albumin excretion rate 59 prior chemotherapy regimens 59 BRCA1 mutation carriers 59 underwent coronary angiography 59 hsCRP levels 59 alanine aminotransferase ALT 59 ACR Pedi 59 antibody titer 59 sentinel nodes 59 upper endoscopy 59 HER2 expression 59 Hypertensive adverse reactions 59 HbA1C 59 postintervention 59 COPD exacerbation 59 liver biopsy 59 intravenous bisphosphonates 59 disposable TMR 59 endometrial biopsy 59 nondiabetic patients 59 statistical significance p 59 subclinical hyperthyroidism 59 mm Hg diastolic 59 tuberculin skin testing 59 prostate biopsies 59 HBeAg negative 59 coinfected patients 59 HBeAg seroconversion 59 glomerular filtration rate 59 EUS FNA 59 severe exacerbations 59 British dadA 59 Univariate 59 ASPS statistics 59 preoperative radiotherapy 59 HBsAg 59 AVODART 59 symptomatic GERD 59 severe neutropenia 59 Euro Libor #.# 59 -#.# log# 59 Pharmacokinetic parameters 59 mcg QD 59 glycated hemoglobin 59 BMD measurements 59 clinico pathological 59 PSADT 59 bepotastine besilate nasal spray 59 certolizumab 59 aged ≥ 59 extracolonic findings 59 mmHg diastolic 59 Viral load 59 sustained virological response 59 randomized controlled trials RCTs 58 aminotransferases 58 NNT = 58 underwent radical prostatectomy 58 hepatectomy 58 pT3 58 serum lipid levels 58 μg L 58 baseline Hb 58 nonmelanoma skin cancers 58 coronary arteriography 58 mU liter 58 nanograms milliliter 58 radioiodine therapy 58 EDSS score 58 decompensated liver disease 58 abnormal cytology 58 subtyped 58 oral antidiabetic medication 58 episodic migraine sufferers 58 XIENCE V PROMUS Stent 58 arterial thromboembolic events 58 Refinery utilization rebounded 58 #mg q8h 58 MMSE score 58 prior nephrectomy 58 ICSI cycles 58 preoperative chemotherapy 58 REYATAZ r arm 58 Rectal cancer 58 FOLFOX4 58 hepatocellular carcinomas 58 bronchoscopies 58 DLQI 58 Hb A1C 58 abnormal Pap 58 HBeAg negative patients 58 prostate specific 58 antidiabetic medication 58 oral antidiabetes 58 tuberculin test 58 statewide unadjusted jobless 58 serum aminotransferase levels 58 bezafibrate 58 statin monotherapy 58 metabolically healthy 58 acrylamide intake 58 transrectal ultrasound guided 58 carotid stenosis 58 APTIVUS r 58 Hemoglobin A1C 58 hypophosphatemia 58 blood counts CBCs 58 basal cell nevus syndrome 58 timepoint 58 Fecal occult blood 58 serum HCV RNA 58 System IPSS 58 Cervista HPV HR 58 baseline A1C 58 recurrent UTI 58 upper endoscopies 58 haematologic 58 macroalbuminuria 58 ejection fractions 58 CABG surgeries 58 postoperative complication 58 PCA3 scores 58 CC genotype 58 posttreatment 58 nonobstructive CAD 58 preoperative PSA 58 Tumors shrank 58 serum creatinine levels 58 symptomatic BPH 58 mEq L 58 rectal tenesmus 58 lung resections 58 MGUS 58 aldosterone antagonist 58 Cystatin C 58 stent stenosis 58 cT3 prostate cancer 58 Antipsychotic medications 58 endometrial hyperplasia 58 Triglyceride levels 58 leukocyte count 58 creatinine levels 58 faecal occult blood 58 acetaminophen codeine 58 stage IIIb IV 58 detectable HCV RNA 58 atherogenic dyslipidemia 58 adenomatous polyps 58 colonoscopy flexible sigmoidoscopy 58 Repliform R revenues 58 seronegative 58 -#.# log# copies mL 58 tipranavir r 58 IU ml 58 ADCS CGIC 58 logistic regression analyzes 57 OPT CHF 57 Mg Uk 57 heterosexually acquired 57 metastatic lung cancer 57 receiving antiretroviral therapy 57 esophagogastroduodenoscopy 57 sustained virologic response 57 undergone splenectomy 57 asymptomatic hypothyroidism 57 abnormal Pap test 57 confidence interval #.#-#.# 57 abnormal p# biomarker 57 renal biopsy 57 concomitant antibiotics 57 HOMA IR 57 abdominal ultrasounds 57 mg kg Hematide 57 postoperative chemotherapy 57 fullyear outturn represents 57 aspartate aminotransferase 57 corticosteroid dose 57 pancreatic resection 57 hematuria 57 Operative mortality 57 beta carotene supplementation 57 windpipe transplants 57 morphometric vertebral fractures 57 Adenomas 57 Subgroup analyzes 57 Radical prostatectomy 57 prednisone prednisolone plus 57 Consolidated PRASM 57 chemoradiation therapy 57 intact parathyroid hormone 57 thyrotropin levels 57 ug dose 57 CR nPR 57 serum urate 57 cTnT levels 57 thyroid stimulating hormone 57 ertapenem 57 hemoglobin A1c levels 57 Engerix B 57 mg/m2 dose 57 spirometric 57 PAP smear 57 gonococcal infections 57 RLS sufferers 57 marketed workover rigs 57 HealthGrades analyzed 57 DAS# [002] 57 abnormal Pap smear 57 KRAS mutations 57 aminotransferase ALT 57 conventional cytology 57 prospectively enrolled 57 polycystic ovary syndrome PCOS 57 genotypic resistance 57 dietary questionnaires 57 antigen PSA 57 #mg doses [002] 57 Prostate Specific Antigen 57 antiretroviral naïve 57 precancerous polyp 57 HSCT 57 coinfected 57 latent celiac disease 57 intestinal biopsy 57 pathologic examination 57 mmHg systolic 57 histopathologic examination 57 Pneumococcal vaccines 57 Kaplan Meier analysis 57 BLLs 57 hemodialysis patients 57 timepoints 57 Lung transplantation 57 Nonaccrual loans totaled 57 tipranavir ritonavir 57 creatinine clearance 57 TEB adjustment 57 elevated CRP 57 fecal occult 57 DXA scan 57 diagnostic angiography 57 EDSS scores 57 mcg Albuferon 57 IELT 57 dysglycemia 57 underwent resection 57 Index CDAI score 57 weekly intravenous infusions 57 colorectal adenoma 57 urate lowering therapy 57 conventional coronary angiography 57 protein excretion 57 leukopenia 57 nondiabetics 57 dose Iluvien 57 ICDs implanted 57 dose escalation phase 57 squamous histology 57 noninterest expense totaled 57 Isolaz procedures 57 radical nephrectomy 57 elevated triglyceride levels 57 virologic failure 57 nonfasting 57 #mg dose [002] 57 liver transplant recipients 57 transvaginal sonography 57 eGFR 57 hypogonadal men 57 umol L 57 USPSTF recommends 57 Cochrane reviewers 57 glycosylated hemoglobin HbA1c 57 lipid lowering medication 57 μmol L 57 UPDRS motor 57 serum ferritin 57 nonobese 57 diverticular bleeding 57 serum phosphate 57 oral glucose tolerance 57 transaminase elevations 57 N telopeptide 57 recurrent VTE 57 chlamydial infection 57 concomitant medications 57 aminotransferase levels 57 RLEC adjusted EBITDA 57 DETROL LA 57 guaiac 57 mU L 57 μg dL 57 Merckx Hinault Miguel Indurain 57 HIV uninfected 57 pmol L 56 mm ³ 56 thyroglobulin 56 glycosylated hemoglobin 56 EXJADE 56 â ‰ ¥ 56 NIHSS score 56 microscopic hematuria 56 alanine aminotransferase 56 microalbuminuria 56 mean baseline A1C 56 vaccinees 56 CHD CVD 56 atypical ductal hyperplasia 56 creatinine ratio 56 TKAs 56 serum potassium 56 anti HBs 56 CrCl 56 OGTT 56 female endoscopist 56 Flexi Scope 56 endometriosis ovarian cysts 56 nonvertebral fractures 56 Nesiritide 56 moderate renal impairment 56 orofacial clefts 56 CDAI score 56 serum prostate 56 #mg BID [001] 56 multivariate logistic regression 56 BRCA2 mutation carriers 56 intravitreal injections 56 adenoma 56 glioma tumors 56 URTI 56 genital HSV 56 skin prick 56 neutropaenia 56 BENICAR HCT 56 Myelosuppression 56 prolonged QT interval 56 sCJD 56 coronary angiograms 56 folic acid takers 56 CMV infection 56 ADPKD 56 MoxDuo TM IR 56 PBDE chemicals 56 transesophageal echocardiography 56 abnormal mammogram 56 anti JCV antibodies 56 biochemical recurrence 56 cerebral angiography 56 salmeterol fluticasone propionate 56 sUA 56 HBV DNA levels 56 pelvic lymphadenectomy 56 abdominal ultrasound 56 HIV HCV coinfected 56 urinary BPA 56 oral allopurinol 56 Swedish Mammography Cohort 56 apnea hypopnea index 56 NAbs 56 univariate analyzes 56 quetiapine risperidone 56 ng dL 56 neurologic complications 56 SEISMIC Trial 56 fecal occult blood 56 endoscopic remission 56 gross hematuria 56 Prepaid churn 56 adjunctive placebo 56 deCODE BreastCancer TM 56 RECORD1 56 flutamide 56 endometrial thickness 56 Abdominal ultrasound 56 Thyroid nodules 56 mg Lucentis 56 elevated LDL cholesterol 56 Ishak fibrosis score 56 adiponectin concentrations 56 HGPIN 56 Screening Trial 56 atypical hyperplasia 56 coronary stenosis 56 perioperative mortality 56 benign nodules 56 postoperative infection 56 SLNB 56 peritoneal cancer 56 HbA1C levels 56 4mg/kg 56 CT colonography CTC 56 β blockers 56 dosing cohort 56 duplex ultrasonography 56 cervical cancer precursors 56 undetectable viral 56 renal transplants 56 anastrazole 56 differentiated thyroid 56 undetectable HCV RNA 56 NYHA functional class 56 ACTEMRA TM 56 conventional angiography 56 urine dipstick 56 drank decaffeinated coffee 56 mcg linaclotide 56 FEET WATER 56 postmenopausal osteoporotic women 56 serum selenium 56 Brief Psychiatric 56 nonmelanoma skin cancer 56 adjunctive ABILIFY 56 oxygen desaturation 56 obstructive coronary artery 56 FOLPI regimen 56 lobular cancer 56 micrograms mcg 56 angioplasties stents 56 milliliters mL 56 prospectively stratified 56 NAMCS 56 hypoglycemic episodes 56 rectal tenesmus #.# 56 recurrent tonsillitis 56 ELISPOT 56 lymphocyte count 56 albumin excretion 56 serum urate levels 56 prostate biopsy 56 Study ARIC 56 transfusion syndrome 56 troponin T 56 Primary endpoints 56 F FDG PET 56 pleural fluid 56 histologically confirmed 56 urine NGAL 56 AST ALT 56 mmol L. 56 QTcF 56 MRSA colonization 56 MADRS score 56 Insulin sensitivity 56 hip resurfacing arthroplasty 56 NIHSS 56 Nonresidential structures 56 elevated alkaline phosphatase 56 postoperative mortality 56 aminotransferase elevations greater 56 #.#mg/dL 56 clinically evaluable patients 56 invasive lobular 56 NovoLog ® Mix 56 overt hypothyroidism 56 BCG vaccinated 56 Irrigated fields 56 rimonabant #mg 56 screening colonoscopy 55 IIIa inhibitors 55 FDG PET imaging 55 μg doses 55 stable angina 55 Biopsies 55 median CD4 55 undergo prostate biopsy 55 axillary lymph node 55 noninterest expense decreased 55 ductal cancer 55 Ejection Fraction 55 nonsevere disability 55 PREZISTA r 55 PREZISTA ritonavir 55 fasting serum 55 RSV infects 55 postprocedure 55 Irritable bowel syndrome IBS 55 Noninterest expense totaled 55 malignant neoplasm 55 #mmHg [001] 55 nonfasting triglyceride levels 55 statin cholesterol lowering 55 FDG-PET/CT 55 ng dl 55 flexible sigmoidoscopy 55 bowel polyps 55 + PH# 55 serum calcium 55 multiple logistic regression 55 posttest 55 bronchial lavage 55 Hazard Ratio HR 55 penicillin allergy 55 log# copies mL 55 autoantibody positive 55 lipid lowering medications 55 ritonavir boosted 55 congenital toxoplasmosis 55 Prostate specific antigen 55 asthma exacerbation 55 sonographic examinations 55 Wisconsin Sleep Cohort 55 Prehypertension 55 abdominal hysterectomy 55 prehypertensive 55 serum thyroglobulin 55 baseline serum creatinine 55 serum clusterin levels 55 transaminase levels 55 PROCTOCORT ® Suppository Hydrocortisone 55 AIR CF1 55 nmol l 55 Complication rates 55 atorvastatin #mg 55 sputum induction 55 underwent liver transplantation 55 digital rectal exams 55 inert placebo 55 fluvastatin 55 Adjuvant chemotherapy 55 plasma selenium 55 urinary N telopeptide 55 symptomatic carotid stenosis 55 8 OHdG 55 coronary calcification 55 PAP smears 55 DAS# scores 55 Proteinuria 55 C Reactive Protein 55 methotrexate monotherapy 55 pT2 55 vincristine doxorubicin 55 exhaled nitric oxide 55 coronary angiography 55 MERIT ES 55 mg kg dose 55 trials RCTs 55 Non inferiority 55 elective PCI 55 neoadjuvant therapy 55 titrated glipizide 55 undergoing CABG 55 chronic rhinosinusitis 55 lipid lowering agents 55 date Wholesale Leathercraft 55 BladderChek 55 serum HBV DNA 55 fructosamine 55 permanently discontinue Vectibix 55 colorectal neoplasms 55 BMI ≥ 55 PCIs 55 LEXIVA r 55 cTnT 55 malignant lesions 55 dimensional computed tomography 55 Urinary tract infections UTIs 55 GfK Polonia poll 55 Creatinine 55 CCyR 55 mg ustekinumab 55 Available Seat Kilometres ASKs 55 polyp recurrence 55 μg d 55 QIDS SR 55 treatment emergent AEs 55 A1c levels 55 colorectal bowel 55 metastatic lesion 55 biopsy specimens 55 HbA1c levels 55 mild renal insufficiency 55 axillary lymph nodes 55 subclinical hypothyroidism 55 intravenous RSD# 55 cervical carcinoma 55 FHLB borrowings decreased 55 gallstone disease 55 tPSA 55 mild gestational diabetes 55 MELD scores 55 cervical cytology 55 cardiac troponin T 55 Fetal heartbeats 55 immunohistochemical analysis 55 placebo fluoxetine 55 MARRIOTT REVENUES totaled 55 serum chemistries 55 mcg kg REBETOL 55 transient elastography 55 serum vitamin D 55 subarachnoid hemorrhages 55 transferrin saturation 55 severe renal impairment 55 ARCOXIA 55 mCi 55 exhaled NO 55 μg dl 55 dosing cohorts 55 dizziness nausea diarrhea 55 incontinence episodes 55 #mg ATC 55 QM MSP 55 budesonide pMDI 55 subtrochanteric 55 LVNC 55 robotic prostatectomies 55 revascularization procedure 55 splenectomized patients 55 Androgen Deprivation Therapy 55 colorectal polyp 55 invasive prenatal 55 DOI #.#/art.# 55 incisional biopsy 55 seropositive 55 salpingo oophorectomy 55 cholesterol triglyceride 55 #mg/dL [001] 55 cotinine byproduct 55 undetectable PSA 55 rheumatoid factor 55 buprenorphine implants 55 pretest probability 55 insulin detemir 55 logistic regression models 55 pharyngeal cancer 55 folate vitamin B6 55 albumin creatinine ratio 55 KRAS mutation 55 logistic regression analysis 55 multivariable analysis 55 rhinovirus infections 55 seroprotective 55 cilostazol 55 ATACAND 55 sigmoidoscopies 55 TP# mutations 55 MACCE 55 x ULN 55 GH deficiency 55 screening colonoscopies 55 D dimer 55 interquartile range 55 % Confidence Interval 55 semiquantitative 55 -#.# mg dL [002] 55 neutrophil counts 55 placebo PBO 55 Munghana Lonene Listenership 55 Jack Pirozzolo 55 QTc prolongation 55 osteosarcomas 55 Adjusted EBITDAR margin 55 seminoma 55 intraobserver 55 fluoroscopy guided 55 irregular menstrual cycles 55 careHPV 55 echocardiographic parameters 55 prostates removed 55 ABC/3TC 55 CSDs Dr Pepper 55 hematopoietic cancers 55 plain radiographs 55 noncancerous prostate 55 acid suppressive medication 55 placebo controlled clinical trials 55 Retail Leathercraft posted 55 HIV seronegative 55 potent antiretroviral therapy 55 vaginal progesterone gel 55 C. diff infections 55 triacylglycerol concentrations 55 ug kg 55 Hemoglobin A1c 55 cirrhotic CHC monoinfected patients 54 overt nephropathy 54 mg Androxal 54 Health Initiative Observational 54 Baseline characteristics 54 clinically localized prostate 54 univariate analysis 54 mg FV 54 mg RDEA# 54 Membership fluctuates 54 NPH insulin 54 pyridostigmine 54 cytologic 54 NNRTI resistance 54 intracerebral hemorrhages 54 mmol liter 54 barium enema 54 mg Pycnogenol 54 milligrams deciliter 54 stone formers 54 μg g 54 removed laparoscopically 54 reoperations 54 REMICADE monotherapy 54 neoplasias 54 peginterferon alfa 2a 54 intraocular inflammation 54 mIU L 54 Mantoux test 54 immunochemical 54 Carotid Revascularization Endarterectomy vs. 54 test OGTT 54 IRLS score 54 PFOS PFOA 54 hemoglobin A1C HbA1C 54 metformin monotherapy 54 ELISpot 54 lactate dehydrogenase 54 urinary protein 54 hypokalemia 54 Chlamydia infection 54 FOLPI 54 Loeys Dietz 54 elevated fasting glucose 54 Prostate Cancer Recurrence 54 continuously abstinent 54 PREMARIN Vaginal Cream 54 hamartomas 54 HCV SPRINT 54 NATRECOR R 54 lumbar spine BMD 54 ProShares Ultra Dow# 54 triglyceride concentration 54 eosinophil count 54 invasive coronary angiography 54 bacterial isolates 54 deCODE ProstateCancer TM 54 beta blocker therapy 54 Depressive disorders afflict 54 multivariate analyzes 54 serum sodium concentration 54 Hair follicle 54 peginterferon 54 XELOX 54 PLCO 54 R rilonacept Injection 54 HIV tropism 54 homocysteine concentrations 54 Bone density 54 baseline PASI 54 Metres NTKM went 54 hematological parameters 54 Cotinine 54 mm Hg systolic 54 tuberculin skin test 54 mcg BID 54 OBPM 54 Cardiovasc Res 54 Pandemic Influenza H#N# 54 radical prostatectomies 54 mycophenolate mofetil 54 neuropathy sensory 54 NATRECOR ® 54 colonography 54 Netherlands Cohort Study 54 steroid dexamethasone 54 grade squamous intraepithelial 54 USMTC program 54 tuberculin skin tests 54 serum estradiol 54 gauge vitrectomy 54 telomere lengths 54 HER2 positive cancers 54 Soriatane R acitretin capsules 54 Clinical Diagnostics segment 54 habitual snorers 54 cystoscopic 54 civilian noninstitutionalized population 54 wedge resection 54 TURBT 54 prostate specific antigen 54 relapsed SCLC 54 Rh factor 54 chlorambucil 54 psychiatric comorbidities 54 erythrocyte sedimentation rate 54 CARDIA study 54 d dimer 54 HER2 overexpression 54 complete cytogenetic response 54 got Abbott MitraClip 54 deciliter 54 transurethral resection 54 intensive statin therapy 54 % CI #.#-#.# [007] 54 gestational hypertension 54 axillary node dissection 54 experienced virologic failure 54 Active Trader DARTs 54 grade cervical intraepithelial 54 TDF FTC 54 hyperphenylalaninemia HPA due 54 PXA signal 54 baseline FEV 54 lobular carcinoma 54 Apidra ® 54 fasting insulin 54 serologic 54 completely resected 54 lamivudine monotherapy 54 Staph germs 54 nasopharyngitis upper 54 pentoxifylline 54 deCODE AF TM 54 histologic subtype 54 Sees FY# adj EPS 54 serologic testing 54 hypoglycemic events 54 #Gy 54 virologically 54 Hum Mol Genet 54 serum cortisol 54 inguinal hernia repair 54 chewed sugarless gum 54 Adjusted EBITDA1 54 hepatic enzymes 54 CHD mortality 54 colonoscopy detects precancerous polyps 54 stool specimen 54 Case persistency 54 Amniocentesis 54 myocardial infarctions MIs 54 precancer 54 Scale EDSS score 54 dapagliflozin plus 54 BEXXAR Therapeutic Regimen 54 cystatin C 54 pathologic diagnosis 54 Hemoccult II 54 hematologic parameters 54 thiazide diuretics 54 point Likert scale 54 troponins 54 5-FU/LV 54 ovarian endometrial 54 Noninterest Expense Noninterest expense 54 mcg dL 54 confidence intervals CIs 54 ductal carcinomas 54 #ng/ml 54 HIV RNA 54 repigmentation 54 histological subtype 54 anemia hemoglobin 54 distant metastasis 54 hemoglobin A1c 54 locoregional recurrence 54 μg dose 54 LOW PRICE STOCK 54 sputum specimens 54 chest radiography 54 abacavir lamivudine 54 fasting blood glucose 54 Its ROA 54 ductal breast cancer 54 binary restenosis 54 THIS STUDY 54 serum potassium levels 54 pulsatile flow 54 cGy 54 FLT3 mutations 54 acute STEMI 54 abnormal mammograms 54 cognitively normal 54 adverse reactions incidence 54 triglyceride concentrations 54 Donated organs 54 Hematocrit 54 Lucentis injections 54 #F FDG PET 54 invasive cervical cancers 54 histopathologic 54 Unified Parkinson Disease 54 transaminases 54 antihypertensive medications 54 HNSCC 54 histologically proven 54 genital ulcers 54 recurrent wheezing 54 HER2 amplification 54 log# reduction 54 highest tertile 54 semistructured interviews 54 AGHD 54 maternal serum 54 gonococcal infection 54 overnight polysomnography 54 atopic 54 Serum creatinine